AtriCure (ATRC) Invested Capital (2010 - 2026)

AtriCure (ATRC) has 17 years of Invested Capital data on file, last reported at $552.7 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $552.7 million, up 7.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $552.7 million (up 7.01% YoY), and the FY2025 annual result was $491.9 million, up 6.07% from the prior year.
• Invested Capital improved to $552.7 million in Q1 2026 per ATRC's latest filing, from $491.9 million in the prior quarter.
• Over five years, Invested Capital peaked at $552.7 million in Q1 2026 and troughed at $460.7 million in Q3 2022.
• A 5-year average of $506.5 million and a median of $516.7 million in 2022 frame the typical range for Invested Capital.
• On a YoY basis, Invested Capital climbed as much as 34.18% in 2022 and fell as far as 16.01% in 2022.
• A 5-year view of Invested Capital shows it stood at $466.9 million in 2022, then gained by 1.8% to $475.3 million in 2023, then decreased by 2.43% to $463.8 million in 2024, then gained by 6.07% to $491.9 million in 2025, then rose by 12.35% to $552.7 million in 2026.
• Business Quant data shows ATRC's Invested Capital at $552.7 million in Q1 2026, $491.9 million in Q4 2025, and $538.4 million in Q3 2025.